Welcome to CDC stacks | 2013 ALS annual meeting summary report : executive summary - 27708 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
2013 ALS annual meeting summary report : executive summary
  • Published Date:
    2013
  • Language:
    English
Filetype[PDF-185.92 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. 2016 Annual ALS Surveillance Meeting executive summary, August 3-4, 2016
    Corporate Author:
    United States. Agency for Toxic Substances and Disease Registry.
    Published:
    12/7/16
    Description:
    Due to the limited information on the unknown cause(s) of Amyotrophic Lateral Sclerosis (ALS), the Agency for Toxic Substances and Disease Registry (ATSDR) established the National ALS Registry in 2010. The primary purpose of the ALS Registry is to e...
    File Type:
    Filetype[PDF - 79.63 KB]
  2. National Amyotrophic Lateral Sclerosis (ALS) Biorepository Governance : February 12, 2013 summary report
    Corporate Author:
    United States. Agency for Toxic Substances and Disease Registry.
    Published:
    2013
    Description:
    Minutes of the Meeting, February 12, 2013 : Purpose: Discuss current governance practices with federal biorepositories and provide comments on proposed governance policies and procedures for the National ALS Biorepository.
    File Type:
    Filetype[PDF - 516.92 KB]
  3. ATSDR’s Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : August 13 – 14, 2014 summary report
    Corporate Author:
    United States. Agency for Toxic Substances and Disease Registry.
    Published:
    2014
    Description:
    This document has not been revised or edited to conform to agency standards. The findings and conclusions in this report are those of the meeting presenters and attendees and do not necessarily represent the views of the Agency for Toxic Substances a...
    File Type:
    Filetype[PDF - 3.59 MB]
  4. Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : August 1-2, 2017 summary report meeting transcript
    Corporate Author:
    United States. Agency for Toxic Substances and Disease Registry.
    Published:
    12/1/17
    Description:
    Amyotrophic Lateral Sclerosis (ALS) continues to be a mysterious fatal disease with no known cause(s) for approximately 90-95 percent of those diagnosed with the disease. It is for this reason that the Agency for Toxic Substances and Disease Registry...
    File Type:
    Filetype[PDF - 3.56 MB]
  5. ATSDR’s Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : July 22-23, 2015 summary meeting
    Corporate Author:
    United States. Agency for Toxic Substances and Disease Registry.
    Published:
    5/6/16
    Description:
    Due to the limited information on the unknown cause(s) of Amyotrophic Lateral Sclerosis (ALS), the Agency for Toxic Substances and Disease Registry (ATSDR) established the National ALS Registry in 2010. The primary purpose of the ALS Registry is to d...
    File Type:
    Filetype[PDF - 3.58 MB]